Patricia Fast - Concepedia

Author

Patricia Fast

International AIDS Vaccine Initiative

Also Known As

Fast, P., Fast, Patricia E., Karita, Etienne, P E FAST, P E Fast, P Fast, P. E. Fast, P. FAST, P. Fast, P.E. Fast

161

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

International AIDS Vaccine Initiative Emmes (United States)Uganda Virus Research Institute Imperial College London National Institute of Allergy and Infectious Diseases

About

Patricia Fast is an author at International AIDS Vaccine Initiative specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	2K
2	Epidemiology	7	7	444
3	Public Health	4	4	275
4	Allergy	2	2	53
5	Natural Sciences	1	1	232

Patricia Fast

Publications

Citations

H-Index

Page 1

	Year	Citations
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm Melissa Simek, Wasima Rida, Frances Priddy, Journal of Virology	2009	577
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser, New England Journal of Medicine	2015	404
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial Angela Huttner, Julie-Anne Dayer, Sabine Yerly, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyPreventive MedicineImmunology	2015	276
A human protein specific for the immunoglobulin octamer DNA motif contains a functional homeobox domain H S Ko, Patricia Fast, Wesley O. McBride, Cell ImmunogeneticsHuman Protein SpecificNatural SciencesImmunologyProtein Genetics	1988	232
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine Enoch Muyanja, Aloysius Ssemaganda, Pearline Ngauv, Journal of Clinical Investigation	2014	219
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1<sub>Mn</sub>gp120, HIV‐1<sub>SF2</sub>Recombinant gp120, or Both Vaccines in Seronegative Adults Mary Lou Clements‐Mann, Kent J. Weinhold, Thomas J. Matthews, The Journal of Infectious Diseases ImmunodeficienciesImmunologyImmunodominanceHiv-1sf2 Neutralizing AntibodiesHuman Immunodeficiency Virus	1998	190
In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers Sandhya Vasan, Arlene Hurley, Sarah J. Schlesinger, PLoS ONE	2011	184
A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8<sup>+</sup>Cytotoxic T Lymphocyte Responses in Seronegative Volunteers Thomas G. Evans, Michael C. Keefer, Kent J. Weinhold, The Journal of Infectious Diseases ImmunodeficienciesImmunologyGenes Given AloneImmunodominancePathology	1999	173
Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers Gaudensia Mutua, Eduard J. Sanders, Peter Mugo, PLoS ONE	2012	151
Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination Alison E. Mahan, Madeleine F. Jennewein, Todd J. Suscovich, PLoS Pathogens	2016	145

Page 1